129 related articles for article (PubMed ID: 15382064)
1. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
Oldford SA; Robb JD; Watson PH; Drover S
Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
[TBL] [Abstract][Full Text] [Related]
3. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma.
Matoba K; Iizuka N; Gondo T; Ishihara T; Yamada-Okabe H; Tamesa T; Takemoto N; Hashimoto K; Sakamoto K; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Cancer; 2005 Jun; 115(2):231-40. PubMed ID: 15688398
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
5. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
Oldford SA; Robb JD; Codner D; Gadag V; Watson PH; Drover S
Int Immunol; 2006 Nov; 18(11):1591-602. PubMed ID: 16987935
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
9. MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.
Saito T; Kimura M; Kawasaki T; Sato S; Tomita Y
Cancer Lett; 1997 May; 115(1):121-7. PubMed ID: 9097987
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
11. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
[TBL] [Abstract][Full Text] [Related]
12. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
[TBL] [Abstract][Full Text] [Related]
13. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
Lucin K; Iternicka Z; Jonjić N
Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
[TBL] [Abstract][Full Text] [Related]
15. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
[TBL] [Abstract][Full Text] [Related]
16. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Georgiannos SN; Renaut A; Goode AW; Sheaff M
Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
[TBL] [Abstract][Full Text] [Related]
17. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
18. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
19. HLA expression in basal cell carcinomas.
Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
[TBL] [Abstract][Full Text] [Related]
20. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]